Pers Med News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Pers med. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Pers Med Today - Breaking & Trending Today
Transforming mental health systems globally: principles and policy recommendations thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.
Targeting CLDN18.2 with zolbetuximab significantly prolonged progression-free survival and overall survival when combined with mFOLFOX6 versus placebo plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma. Zolbetuximab plus mFOLFOX6 might represent a new first-line treatment in these patients. ....